Our assessment
VivioMD publishes prices for a daily dissolvable tablet, two weekly injection options and branded Ozempic. The compounded product tiles do not identify their exact active ingredients, and starting-price labels need clarification alongside the flat-dose pricing promise. The reviewed FAQ also contained an unapplied copy edit. Confirm the formulation, pharmacy and final charge before enrolling.
A tablet, two injections and a branded line, all priced in public
The homepage carries four product tiles, each with a figure and a stock label: a dissolvable tablet taken once a day, a weekly injection, a weekly dual-incretin injection, and branded Ozempic. Nothing is gated behind a quiz.
The daily tablet and weekly injection have the same listed starting price. Their labels alone do not establish equivalent ingredients, dosing or effectiveness; ask the prescriber about the exact formulations.
The branded line sits on the same screen as the compounded ones, so you can see the gap between the two channels without doing any work.
The tiles don't name the drug
Three of the four tiles say only GLP-1, or GLP-1 plus GIP. Semaglutide and tirzepatide are named on the policy pages, and four approved brand names appear in a trademark disclaimer, but none of that is attached to a price.
Ask which active ingredient and formulation each price covers. A dual-incretin label alone is insufficient to identify the drug you would receive.
The branded tile is the exception. It names Ozempic, and a brand name tells you its molecule.
An edit that was published instead of applied
One FAQ answer on the live homepage reads as the original sentence, a closing quotation mark, the words Replace with, and then the replacement sentence. Both versions are sitting there for anyone to read.
The edit itself is small and telling. It removes a claim that the dispensing pharmacy is FDA-regulated. VivioMD received an FDA warning letter in June 2026 over false and misleading claims and misbranding.
What matters for you is simpler: this is a live, visible defect on the page you would read before paying.
Flat, or starting at
A list of reasons to choose the service includes flat pricing that never goes up as the dose increases. Every figure below it is labeled as a starting point.
Those are two different promises about the same numbers, and VivioMD makes both. Treat the figures as floors until it says otherwise in writing.
No membership statement appears anywhere. The site says there are no long-term commitments, no cancellation fees and no hidden fees, none of which tells you whether a membership exists.
VivioMD's published pricing
Prices re-verified September 2026
| Medication | Price |
|---|---|
| MedicationGlp-1 (compounded-oral) — one dissolvable tablet per day | Price$299/mostarting price, per month; the priced tile doesn't name the specific medication, so this is filed as a general GLP-1 price |
| MedicationGlp-1 (compounded) — one injection per week | Price$299/mostarting price, per month; the priced tile doesn't name the specific medication |
| MedicationGlp-1 (compounded) — GLP-1 + GIP, one injection per week | Price$398/mostarting price, per month; the priced tile doesn't name the specific medication, even though the GLP-1+GIP combination suggests tirzepatide |
| MedicationSemaglutide (brand) — Ozempic | Price$1,299/mostarting price, per month, for the branded Ozempic listing; the seller notes availability is subject to change |
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
See VivioMD's current price →Who VivioMD suits
Good fit if
- Readers who want a daily tablet instead of a weekly injection and want to see what it costs first.
- Buyers comparing a compounded lane against a branded one without starting an intake.
- People who want the operating company, the clinical group and the software platform named separately.
Look elsewhere if
- Anyone who needs to know which molecule they are buying before they pay.
- Buyers who need the compounding pharmacy named.
- Readers who want a figure that won't move as the dose rises, given that the site makes both claims.
- Anyone who wants a stated position on whether a membership fee applies.
What stands out about VivioMD
Strengths
- Sells a needle-free lane and prices it: a daily dissolvable tablet is one of four products priced on the homepage, and it costs the same as the weekly injection
- Prices a branded, cash-pay Ozempic line beside the compounded ones, so the gap between the two channels is visible on one screen without an intake
- Names the operating company on its privacy policy and ties it to the domain in one sentence, and names the clinical group and the intake platform separately from itself
- Prints the trademark disclaimer for all four brand names it mentions and states plainly that it is not affiliated with either manufacturer
Trade-offs
- Received an FDA warning letter (No. 728295, issued June 2026) over false and misleading claims and misbranding
- An FAQ answer includes an unfinished editing instruction about the pharmacy description. Confirm the pharmacy’s identity and licensing directly.
- The page promises flat pricing as the dose increases, but labels its prices “Starting at.” Confirm which doses and services the quoted rate covers.
- Three priced options use GLP-1 or GLP-1/GIP labels without naming the drug. Confirm the medication tied to your quote.
- Names no compounding pharmacy and no prescribing clinician; its fifty-state claim is about where its providers are licensed, and no service-area list appears
How this review was verified
- Every figure comes from the homepage tile that carries it, with that tile's own label. Three of the four tiles name no molecule.
- A promotional banner that ran on this homepage earlier is no longer on the page, so it is not carried here.
- The unexecuted copy edit is quoted from the FAQ block as it appears on the live homepage.
- Checked the FDA's public warning-letter database under the operating company: letter 728295, June 2026, and its text names viviomd.com.
Where VivioMD ranks
VivioMD qualifies for 5 of the 6 boards on this site. A board only ranks the providers that meet its own condition, so a missing board means VivioMD does not publish what that board sorts on.
- Semaglutide — #205 of 334
- Cheapest Overall — #232 of 396
- Brand-Name Available — #80 of 88
- Oral — #69 of 108
- Cash Pay vs Insurance — #71 of 80
Compare VivioMD directly
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
| Provider | Score | From/mo | Full review | Action |
|---|---|---|---|---|
| Belle Health | 10.0/10 | From/mo$109Advertised monthly equivalent for a twelve-month supply; not a verified monthly installment. Six-month rate $119, two-month rate $135, one-month rate $199. Confirm the upfront payment and refill schedule. | Full reviewRead the Belle Health review | Visit |
| Midi Health | 10.0/10 | From/mo$164for a 4-week supply, the lowest of four published dose tiers, including shipping | Full reviewRead the Midi Health review | Visit |
| altRx | 8.6/10 | From/mo$89/moadvertised monthly starting price for a multi-dose vial; confirm plan length and checkout total | Full reviewRead the altRx review | Visit |
Frequently asked questions
Is there an oral option?
Yes. A dissolvable tablet taken once a day is priced on the homepage at the same figure as the weekly injection.
Which drug is in the tablet?
The priced tile doesn't say. Semaglutide and tirzepatide are named only on the policy pages, with no figure attached.
Can I get a brand-name drug?
Yes. Branded Ozempic is priced on the homepage for cash, with a note that availability may change.
Is the price flat or a starting point?
VivioMD says both on the same screen. Treat the figures as starting points until it commits to one answer.
Does VivioMD have an FDA warning letter?
Yes, one issued in June 2026 over false and misleading claims and misbranding.
Ready to compare directly?
VivioMD scores 4.3/10 on this site's rubric. Review the published prices and their conditions above, then confirm your total with the provider. Visiting its site does not commit you to treatment.
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
Visit VivioMD →